Edition:
United States

Molecular Templates Inc (MTEM.OQ)

MTEM.OQ on NASDAQ Stock Exchange Capital Market

9.11USD
23 Feb 2018
Change (% chg)

$-0.10 (-1.09%)
Prev Close
$9.21
Open
$9.27
Day's High
$9.27
Day's Low
$8.84
Volume
19,821
Avg. Vol
34,188
52-wk High
$13.25
52-wk Low
$3.90

Chart for

About

Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. The Company also focused on the... (more)

Overall

Beta: 3.10
Market Cap(Mil.): $245.02
Shares Outstanding(Mil.): 26.90
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 195.87 16.59
EPS (TTM): -- -- --
ROI: -- -0.71 35.07
ROE: -- -3.37 17.79

BRIEF-Molecular Templates Provides Corporate Update And Outlines 2018 Milestones

* MOLECULAR TEMPLATES PROVIDES CORPORATE UPDATE AND OUTLINES 2018 MILESTONES

Jan 05 2018

BRIEF-Molecular Templates appoints Adam Cutler as CFO

* Molecular Templates strengthens management team with appointment of Adam Cutler as Chief Financial Officer

Nov 14 2017

BRIEF-Molecular Templates Q3 loss per share $0.62

* Molecular Templates, Inc. Reports third quarter 2017 financial results

Nov 14 2017

BRIEF-AbCheck and Molecular Templates collaborate to discover therapeutic oncology leads

* Says Abcheck will use Absieve discovery platform to deliver antibodies against biological targets selected by Molecular Templates​

Oct 25 2017

BRIEF-Molecular Templates files for sale of 11.6 mln shares of common stock by selling stockholders‍​

* Molecular Templates Inc - files for sale of 11.6 million shares of common stock by selling stockholders - sec filing‍​ Source text: (http://bit.ly/2x68onC) Further company coverage:

Sep 15 2017

Competitors

Earnings vs. Estimates